PARADIGM BIOCAPITAL ADVISORS LP Poseida Therapeutics, Inc. Transaction History

PARADIGM BIOCAPITAL ADVISORS LP portfolio value:

$7.30M
portfolio value

Poseida Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 2.07M shares 7.30M $3.53 2.07M